Home
Resources
Publications
Desensitization With Human (Recombinant DNA) Insulin

Desensitization With Human (Recombinant DNA) Insulin

T W Bodendorfer, M E Brown, E H Frankel, B H Palay, S R Fulp

Drug Intell Clin Pharm. 1985 Nov;19(11):827-9.

PMID: 3905321

Abstract:

A 34-year-old woman developed gestational diabetes and was treated with insulin (beef-pork and beef) and oral therapy at various periods. She developed an insulin allergy; however, attempts at desensitization with the commercially available purified pork insulin desensitization kit (Eli Lilly Co.) were not successful. Reactivity to human (recombinant DNA) insulin as well as elevated IgE levels and eosinophilia were also demonstrated. A second desensitization attempt with human (recombinant DNA) insulin using a protocol developed by the authors was successful. This report discusses a desensitization procedure using human insulin in an insulin-allergic patient.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP11070738	Insulin (Beef)		11070-73-8	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: